Showkat Ahmad Bhat | Cancer Biology | Best Researcher Award

Posted on by ScienceFather

Dr.Showkat Ahmad Bhat | Cancer Biology | Best Researcher Award

Associate professor, Govt. Medical College Handwara 

Dr. Showkat Ahmad Bhat is an Associate Professor in the Department of Biochemistry at Govt. Medical College (GMC) Handwara & Associated Hospitals, Jammu & Kashmir, India. With extensive experience in clinical biochemistry and molecular biology, his research focuses on cancer biology, proteomics, and epigenetics. He has held various academic and administrative roles in reputed institutions, including GMC Srinagar, GMC Doda, and Al-Falah School of Medical Science & Research Centre. Dr. Bhat has actively contributed to scientific research through multiple funded projects and has received prestigious fellowships from ICMR and CSIR. His expertise extends to communicable diseases, parasitic resistance, and biochemical laboratory techniques. A passionate educator and researcher, he has presented at national and international conferences, winning awards for his contributions to cancer diagnostics and molecular research. His work is dedicated to advancing medical science through innovative biochemical methodologies and fostering academic excellence in medical education.

Profile

Scholar

 Education 

Ph.D. in Biochemistry – BU Rajasthan, Sikar Road, Ajmer M.Sc. in Clinical Biochemistry – University of Kashmir Six-month Internship – Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar B.Sc. in Medical Sciences – S.P. College, Srinagar, Kashmir University  Computer Diploma – NCPUL and DOEACC, Ministry of HRD & IT, Centre Budgam 12th Class (Medical Stream) – Jammu & Kashmir Board of School Education, Srinagar

 Experience 

Associate Professor (2023–Present) – GMC Handwara & Associated Hospitals, Jammu & Kashmir Assistant Professor (2023) – GMC Handwara & Associated Hospitals, Jammu & Kashmir Assistant Professor (2022–2023) – Al-Falah School of Medical Science & Research Centre, Haryana Assistant Professor (2019–2022) – GMC Doda & Associated Hospitals, Jammu & Kashmir Demonstrator/Tutor (2017–2019) – GMC Srinagar, Jammu & Kashmir Research Fellow (2008–2017) – Various ICMR and DST-funded projects on cancer biomarkers, epigenetics, and molecular diagnostics Administrative Roles (2018–Present) – Curriculum Coordinator, Lab Coordinator, IT & Biometric In-Charge, Academic Section Head, Hostel Warden

Awards & Honors 

ICMR Grant (2019) – Workshop on Biochemical Laboratory Techniques CSIR Research Associateship (2017) – RA-3 Scheme Fello DST Travel Grant (2015, 2014, 2013) – Attended international and national conferences, including the 101st & 100th Indian Science Congress Best Oral Presentation Award (2015) – National Conference BIOCME on Advances in Biochemical & Molecular Diagnostics RCR Ross Prize Entrant (2013) – Methylation Status Study in Colorectal Cancer (UK Conference) ICMR Senior Research Fellowship (2013) – Molecular Cancer Diagnostics Various Prestigious Fellowships & Grants – Recognized for outstanding contributions to cancer biomarker research and molecular biochemistry

 Research Focus 

Cancer Biology – Early diagnostic markers, epigenetic modifications, and molecular profiling in gastric and colorectal cancer  Clinical Biochemistry – Biomarkers in disease progression and metabolic disorders Proteomics & Molecular Biology – Protein expression analysis for disease characterization Epigenetics – DNA methylation and gene regulation in carcinogenesis Communicable Diseases – Molecular mechanisms of infectious disease resistance Parasitic Resistance – Studying biochemical adaptations in parasitic infections Biochemical Diagnostics – Development of novel techniques for improved disease detection and treatment strategies

Conclusion

Dr. Showkat Ahmad Bhat’s extensive research experience, significant grants and fellowships, high-quality publications, and innovative projects make him a strong candidate for the Best Researcher Award. Addressing the identified areas for improvement could further enhance his candidacy and contribute to his professional growth.

Puplication

  • Bilal Ahmad, SB., Rehman, M.U., Amin, I., Arif, A., Rasool, S., et al. (2015). “A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).” The Scientific World Journal, 1-6. (281 citations)

 

  • Bhat, S.A., Hassan, T., Majid, S. (2019). “Heavy metal toxicity and their harmful effects on living organisms–a review.” International Journal of Medical Science And Diagnosis Research, 3(1), 106-122. (100 citations)

 

  • Dar, RASNAG M.A., Ahmad, S.M., Bhat, S.A., Ahmed, R., Urwat, U., Mumtaz, P.T., et al. (2017). “Salmonella typhimurium in poultry: a review.” World’s Poultry Science Journal, 73(2), 345-3. (90 citations)

 

  • Bashir, A.H., Bhat, S.A., Majid, S., Hamid, R., et al. (2020). “Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India.” Medical Journal of the Islamic Republic of Iran (MJIRI), 34(5), 1-6. (74 citations)

 

  • Reshi, A.A., Husain, I., Bhat, S.A., Rehman, M.U., Razak, R., et al. (2015). “Bovine mastitis as an evolving disease and its impact on the dairy industry.” IJCRR, 7(5), 48-55. (66 citations)

 

  • Rehman, M.U., Rashid, S.M., Rasool, S., Shakeel, S., Ahmad, B., Ahmad, S.B., et al. (2019). “Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy.” Archives of Physiology and Biochemistry, 125(3), 201-209. (58 citations)

 

  • Bhat, S.A., Mir, M.U.R., Qadir, S., Mehraj, I., et al. (2012). “Prevalence of gastro-intestinal parasitic infections in Sheep of Kashmir valley of India.” Veterinary World, 5(11), 667-671. (48 citations)

 

  • Bhat, S.A., Saravanan, P., Hosamani, M., Basagoudanavar, S.H., et al. (2013). “Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.” Research in Veterinary Science, 95(3), 1217-1223. (45 citations)

 

  • Ahmad, S.B., Rehman, M.U., Fatima, B., Ahmad, B., et al. (2017). “Antifibrotic effects of D-limonene (5(1-methyl-4-[1-methylethenyl]) cyclohexane) in CCl-induced liver toxicity in Wistar rats.” Environmental Toxicology, 1-9. (39 citations)

 

  • Malik, M.A., Bhat, S.A., Fatima, B., Ahmad, S.B., Sidiqui, S., Shrivastava, P. (2016). “Rheum emodi as a valuable medicinal plant.” International Journal of General Medicine and Pharmacy, 5(4), 35-44. (32 citations)

 

  • Bhat, S.A., Majid, S., Wani, H.A., Rashid, S. (2019). “Diagnostic utility of epigenetics in breast cancer–a review.” Cancer Treatment and Research Communications, 19, 100125. (30 citations)

 

  • Bhat, S.A., Mir, M.R., Majid, S., Reshi, A.A., Husain, I., Hassan, T., Ahmad, H. (2019). “Serum lipid profile of breast cancer patients in Kashmir.” (Journal details not provided). (Citation count not mentioned)

 

Ashwani Patil | Cancer Biology | Best Scholar Award

Posted on by ScienceFather

Dr. Ashwani Patil | Cancer Biology | Best Scholar Award

Assistant Professor, Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research India

Dr. Ashwani Patil is a passionate pharmacologist specializing in neurological disorders and cancer research. He completed his Ph.D. in Pharmacology from the Institute of Chemical Technology (ICT), Mumbai, with a focus on preclinical drug development. His research at Bhabha Atomic Research Centre and NIRRH Mumbai deepened his expertise in molecular mechanisms underlying complex diseases. With hands-on experience in animal handling, molecular techniques, and pharmacological testing, he has contributed significantly to understanding disease pathology and potential therapeutic targets for cancer and neurological disorders.

Professional Profile 

Scopus

Scholar

🎓Education

Ph.D. in Pharmaceutical Tech. (Pharmacology), Institute Of Chemical Technology, Mumbai (2024). M. Pharmacy (Pharmacology), R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018). Bachelor of Pharmacy, A.R.A College of Pharmacy, Dhule (2016)

💼Experience

Junior Research Fellow, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018-2019). Research Scholar, Institute of Chemical Technology, Mumbai (2022-Present). Assistant Professor, Dr. D Y Patil Institute of Pharmaceutical Science and Research, Pune (2019-2020, 2024). Expertise in preclinical drug studies, rodent surgery, data analysis, and project planning.

🏆Award and Honor

DAE-ICT Fellowship, 2024. 1st Position in Poster Presentation, 7th International Conference on “Emerging Trends in Drug Development and Delivery” (2024). Research Excellence Award, GEU, Dehradun (2015). Best Paper Presentation Award, TriboIndia 2023, NIT Srinagar

🔬 Research Focus

Dr. Patil’s research spans preclinical drug development, focusing on neurological disorders and cancer. His work investigates therapeutic targets, pharmacodynamics, and the molecular mechanisms of disease pathology. Key areas of interest include rodent models, drug efficacy, safety profiles, and mitochondrial toxicity. His publications highlight cancer cell cytotoxicity and cardioprotective effects, contributing to the understanding of pharmacological agents in disease treatment.

Publications Top Noted

1. Title: Cardioprotective effect of CB1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice

Year: 2024
Authors: Pawar, H.D., Patil, Y., Patil, A., Ojha, S., Goyal, S.N.
Citation: Heliyon, 10(15), e35138
Citations: 0

2. Title: Mitochondria-targeted derivative of pterostilbene, a dietary phytoestrogen, exhibits superior cancer cell cytotoxicity via mitochondrial superoxide mediated induction of autophagy

Year: 2023
Authors: Ibrahim, M.K., Nandha, S.R., Patil, A.S., Sharma, D., Sandur, S.K.
Citation: Advances in Redox Research, 8, 100071
Citations: 1

3. Title: Mitochondriotropic Derivative of Ethyl Ferulate, a Dietary Phenylpropanoid, Exhibits Enhanced Cytotoxicity in Cancer Cells via Mitochondrial Superoxide-Mediated Activation of JNK and AKT Signalling

Year: 2023
Authors: Patil, A.S., Ibrahim, M.K., Sathaye, S., Sharma, D., Sandur, S.K.
Citation: Applied Biochemistry and Biotechnology, 195(3), 2057–2076
Citations: 2

4. Title: Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

Year: 2020
Authors: Patil, A.S., Mahajan, U.B., Agrawal, Y.O., Sharma, C., Goyal, S.N.
Citation: Biomedicine and Pharmacotherapy, 132, 110889
Citations: 17

5. Title: Protective effect of omeprazole and lansoprazole on β-receptor stimulated myocardial infarction in Wistar rats

Year: 2019
Authors: Patil, A.S., Singh, A.D., Mahajan, U.B., Ojha, S., Goyal, S.N.
Citation: Molecular and Cellular Biochemistry, 456(1-2), 105–113
Citations: 17

 

Julien Olivet | Epigenetics | Young Scientist Award

Posted on by ScienceFather

Dr.Julien Olivet | Epigenetics | Young Scientist Award

Dr Julien Olivet Rega Institute/KU Leuven Belgium

Julien Olivet is an exceptional candidate for the Young Scientist Award due to his innovative research in structural and chemical biology, leadership in managing research projects, and significant international recognition. His technical expertise, particularly in cryo-EM and drug discovery, stands out. Additionally, his commitment to teaching and science outreach is commendable. To strengthen his candidacy, he could emphasize the real-world impact of his research and diversify his research topics and publications. Overall, Julien’s achievements and contributions make him a highly deserving nominee for the award.

Publication profile

scholar

🎓 Education

PhD in Biochemistry, Molecular and Cellular Biology, Bioinformatics and ModelingUniversité de Liège, Belgium (2015-2021)Thesis: Selective disruption of histone deacetylase complexes by small-molecule inhibitors.MSc in Chemistry of Life and NanomaterialsUniversité de Namur, Belgium (2013-2015)Thesis: Synthesis of alginate/SiO2-TiO2 hybrid material for cell encapsulation.BSc in ChemistryFacultés Universitaires Notre-Dame de la Paix, Namur, Belgium (2009-2013).High School Diploma in Mathematics, Sciences Institut Notre-Dame de Loverval, Belgium (2003-2009).

🔬 Research Experience

Postdoctoral Fellow, KU Leuven (09/2021-present),Focus: Cryo-EM structures of SIN3 histone deacetylase (HDAC) complexes, managing collaborations, drug design.Visiting Senior Scientist, Université de Liège (09/2021-present)Focus: Inhibitors of SIN3 protein in HDAC complexes, drug screening, spin-off development.PhD Research Fellow, Université de Liège (01/2021-06/2021)Focus: Small molecule screening pipelines, virus-host interactions.Visiting FRS-FNRS/WBI PhD Research Fellow, Harvard Medical School (11/2015-12/2020)
Focus: Chemical genetic selections, protein interaction assays.

🏆 Honours and Awards

NSFC-FWO Collaboration Project Award (2024-2025),Research Foundation Flanders (FWO), Belgium.McKinsey & Company Scientific Award (2022)EUR 5000.Marie Skłodowska-Curie Actions (MSCA) European Postdoctoral Fellowship (2022-2024),EUR 191760.Best Oral Presentation Award (2019)Dana-Farber Cancer Institute, USA.

Publication

  • Maximizing binary interactome mapping with a minimal number of assays
    • Authors: SG Choi, J Olivet, P Cassonnet, PO Vidalain, K Luck, L Lambourne, …
    • Year: 2019
  • The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, …
    • Year: 2021
  • Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells
    • Authors: D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, …
    • Year: 2021
  • A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
    • Authors: J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, …
    • Year: 2022
  • AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
    • Authors: P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, …
    • Year: 2024
  • Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
    • Authors: SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, …
    • Year: 2023
  • A quantitative mapping approach to identify direct interactions within complexomes
    • Authors: P Trepte, C Secker, SG Choi, J Olivet, ES Ramos, P Cassonnet, S Golusik, …
    • Year: 2021
  • Expanding the HDAC druggable landscape beyond enzymatic activity
    • Authors: J Olivet, SG Choi, S Sierra, TM O’Grady, M de la Fuente Revenga, F Laval, …
    • Year: 2023
  • Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, B Galvan, M Cherkaoui, A Desbuleux, …
    • Year: 2021
  • Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions
    • Author: J Olivet
    • Year: 2021

 

🏅 Conclusion

Julien Olivet is a strong candidate for the Young Scientist Award due to his outstanding research achievements, leadership skills, and contributions to the scientific community. His innovative work in cryo-EM and drug discovery, combined with his active role in mentoring and outreach, aligns well with the criteria for the award. Addressing the areas for improvement, particularly in demonstrating the broader impact of his research and expanding his publication portfolio, could further solidify his candidacy.

Mi Rim Lee |cancer science Award | Young Scientist Award

Posted on by ScienceFather

Ms. Mi Rim Lee| Genomics Award | Young Scientist Award

👨‍🏫Profile Summary

John Doe is a dedicated Ph.D. candidate in Cancer Biomedical Science at the National Cancer Center Graduate School of Cancer Science and Policy. With a solid academic background in Biomaterials, he obtained both his Master’s and Bachelor’s degrees from Pusan National University. John’s achievements include prestigious scholarships and poster awards from esteemed institutions like the Korean Society of Laboratory Animal Science and the Korean Cancer Association. His research interests lie at the intersection of cancer biology and biomaterials, aiming to contribute novel insights into cancer treatment and therapy development. John’s academic excellence and commitment to cancer research mark him as a promising young scientist in the field.

🌐 Professional Profiles

Education🎓

2019.09~present: National Cancer Center Graduate School of Cancer Science and Policy Major: Cancer Biomedical Science Degree: Ph.D. candidate, 2017.03~2019.02: Pusan National University Major: Biomaterial Degree: MS. 2011.03~2017.02: Pusan National University Major: Biomaterial Degree: BA.

Awards 🏆

2018.02: Title: Scholarship Student Institution: Korean Society of Laboratory Animal Science 2018.07: Title: Poster Award Institution: Korean Society of Laboratory Animal Science 2019.01: Title: Academic Award Institution: College of Life and Resources Sciences, Pusan National University 2021.06: Title: Poster Award Institution: Korean Cancer Associati

📚Top Noted Publication

  1. Title: New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma
    • Authors: Lee, Y.-S., Im, J., Yang, Y., … Hwang, H., Kim, Y.-H.
    • Journal: Journal of Proteome Research
    • Publication Year: 2024
    • Volume: 23
    • Issue: 3
    • Pages: 905–915

 

  1. Title: Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer
    • Authors: Lee, M.R., Woo, S.M., Kim, M.K., … Kim, Y.-H., Kong, S.-Y.
    • Journal: Cancer Science
    • Publication Year: 2024

 

  1. Title: Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment
    • Authors: Choi, S.I., Lee, Y.-S., Lee, Y.M., … Kim, Y.-H., Kim, I.-H.
    • Journal: Journal of Controlled Release
    • Publication Year: 2023
    • Volume: 360
    • Pages: 940–952

 

  1. Title: Refining Classification of Cholangiocarcinoma Subtypes via Proteogenomic Integration Reveals New Therapeutic Prospects
    • Authors: Cho, S.Y., Hwang, H., Kim, Y.-H., … Park, S.-J., Woo, S.M.
    • Journal: Gastroenterology
    • Publication Year: 2023
    • Volume: 164
    • Issue: 7
    • Pages: 1293–1309

 

  1. Title: Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
    • Authors: Choi, W., Kim, Y.-H., Woo, S.M., … Lee, K.S., Kong, S.-Y.
    • Journal: Cancer Research and Treatment
    • Publication Year: 2023
    • Volume: 55
    • Issue: 4
    • Pages: 1077–1086

 

  1. Title: Establishment of Patient-derived Preclinical Models for Invasive Papillary Cholangiocarcinoma
    • Authors: Mwesige, B., Lee, M.R., Lee, Y.-S., … Woo, S.M., Kim, Y.-H.
    • Journal: Anticancer Research
    • Publication Year: 2022
    • Volume: 42
    • Issue: 1
    • Pages: 599–608